Epidemiology of colorectal cancer

British Medical Bulletin

Volumn 64, Issue , 2002, Pages 1-25

  Boyle, Peter ^a   Leon, Maria Elena ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; COLORECTAL CANCER; ELDERLY CARE; HEALTH CARE PLANNING; HUMAN; INTERNATIONAL COOPERATION; OBSERVATION; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EMIGRATION AND IMMIGRATION; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; WORLD HEALTH;

EID: 0036031826     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/64.1.1     Document Type: Review

References (105)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. Lyon: IARC, 2001 http://wwwdep.iarc.fr/globocan/globocan.htm
2. Edwards BK, Howe HL, Ries LAG et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002; 94: 2766-92
3. Boyle P. Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res 1989; 114: 41-63
4. Parkin DM, Whelan S, Ferlay et al. (eds) Cancer Incidence in Five Continents, vol VII. Lyon: IARC, 1997; 143
5. Howe HL, Wingo PA, Thun MJ et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001; 93: 824-42
6. Haenszel W, Kurihara M. Studies of Japanese migrants I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40: 43-68
7. Boyle P, Golia S, Daly P, Johnston P, Robertson C. Cancer mortality in Ireland. Ann Oncol 2002; In press
8. Morson BC. Gastrointestinal Pathology. Oxford: Blackwell, 1979
9. Peipens LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev 1994; 16: 273-97
10. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumour development. N Engl J Med 1988; 319: 525-32
11. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67
12. Morotomi M, Guillem J, LoGerfo P, Weinstein IB. Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora. Cancer Res 1990; 50: 3595-9
13. Bodmer WF, Balley CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614-8
14. Hall NR, Murday VA, Chapman P et al. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 1994; 30: 180-2
15. Bishop DT, Thomas HJW. The genetics of colorectal cancer. Cancer Surv 1990; 9: 585-604
16. Bishop DT, Hall NR. The genetics of colorectal cancer. Eur J Cancer 1990; 30: 1946-56
17. Cohen AM, Minsky BD, Schilsky RL. Colon cancer. In: deVita VT, Hellman S, Rosenberg SA. (eds). Principles and Practice of Oncology. New York: JB Lippincott, 1993; 1144-84
18. McMichael AJ, Giles GG. Colorectal cancer. In: Doll R, Fraumeni JF, Muir CS. (eds) Cancer Surveys: Trends in Incidence and Mortality. Cold Spring Harbour Press, 1994; 77-98
19. Shephard RJ. Exercise in the prevention and treatment of cancer - An update. Sports Med 1993; 15: 258-80
20. Slattery ML, Potter JD. Physical activity and colon cancer: Confounding or interaction. Med Sci Sports Exerc 2002; 34: 913-9
21. Thune I, Lund E. Physical activity and risk of colorectal cancer in men and women. Br J Cancer 1996; 73: 1134-40
22. Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997; 89: 948-55
23. Willett WC. The search for the causes of breast and colon cancer. Nature 1989; 338: 389-94
24. Vena JE, Graham S, Zielezny M et al. Occupational exercise and risk of cancer. Am J Clin Nutr 1987; 45: 318-27
25. Slattery ML, Schumacher ML, Smith KR et al. Physical activity, diet and role of colon cancer in Utah. Am J Epidemiol 1988; 128: 989-99
26. Whittemore AS, Wu-Williams AH, Lee M et al. Diet, physical activity and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst 1990; 82: 915-26
27. Davidow AI, Neugut AL, Jacobsen JS et al. Recurrent adenomatous polyps and body mass index. Cancer Epidemiol Biomarkers Prev 1996; 5: 313-5
28. Sandler RS, Pritchard ML, Bangiwala SI. Physical activity and the risk of colorectal adenomas. Epidemiology 1995; 6: 602-6
29. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity and risk of colorectal cancer in women (United States). Cancer Causes Control 1996; 7: 253-63
30. Holdstock DJ, Misiewicz JJ, Smith T et al. Propulsion (mass movements) in the human colon and its relationship to meals and somatic activity. Gut 1970; 11: 91-9
31. Simon HB. The immunology of exercise. JAMA 1984; 252: 2735-38
32. Bartram HP, Wynder EL. Physical activity and colon cancer risk? Physiological consideration. Am J Gastroenterol 1989; 84: 109-12
33. Dukas L, Willett WC, Colditz GA, Fuchs CS, Rosner B, Giovannucci EL. Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 2000; 151: 958-64
34. Steinmetz KA, Potter JD. Vegetable, fruit, and cancer I. Epidemiology. Cancer Causes Control 1991; 2: 325-58
35. Michels KB, Giovannucci E, Joshipura KJ et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 2000; 92: 1740-52
36. Willett WC, Stampfer MJ, Colditz GA et al. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 1664-72
37. Willett WC. Diet and cancer: One view at the start of the millennium. Cancer Epidemiol Biomark Prev 2001; 10: 3-8
38. Howe GR, Aronson KJ, Benito E et al. The relationship between dietary fat intake and risk of colorectal cancer: Evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997; 8: 215-28
39. Franceschi S, Favero A. The role of energy and fat in cancers of the breast and colon-rectum in a southern European population. Ann Oncol 1999; 10 (Suppl 6): 61-3
40. Levi F, Pasche C, Lucchini F, La Vecchia C. Macronutrients and colorectal cancer: A Swiss case-control study. Ann Oncol 2002; 13: 369-73
41. Sandhu MS, White I, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: A meta-analytical approach. Cancer Epidemiol Biomark Prev 2001; 10: 439-46
42. Sinha R, Kulldorff M, Chow WH et al. Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas. Cancer Epidemiol Biomark Prev 2001; 10: 559-62
43. Tuyns AJ, Haeltermann M, Kaaks R. Colorectal cancer and the intake of nutrients: Oligosaccharides are a risk factor, fats are not. A case-control study in Belgium. Nutr Cancer 1987; 10: 181-96
44. Kune S, Kune GA, Watson LF. Case-control study of dietary aetiological factors: The Melbourne colorectal cancer study. Nutr Cancer 1987; 9: 21-42
45. Heilbrun LK, Hankin JH, Nomura AMY et al. Colon cancer and dietary fat, phosphorous and calcium in Hawaiian-Japanese men. Am J Clin Nutr 1986; 43: 306-9
46. Fernandez E, d'Avanzo B, Negri E, Franceschi S, La Vecchia C. Diet diversity and the risk of colorectal cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 1996; 5: 433-6
47. Schatzkin A, Lanza E, Corle D et al. Lack of effect of low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000; 342: 1149-55
48. Alberts DS, Martinez ME, Roe D et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 2000; 342: 1156-62
49. Freedman AN, Michalek AM, Marshall JR et al. Familial and nutritional risk factors for p53 overexpression in colorectal cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 285-91
50. Giovannucci E, Pollak MN, Platz EA et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000; 9: 345-9
51. Franceschi S, Dal Maso L, Augustin L et al. Dietary glycemic load and colorectal cancer risk. Ann Oncol 2001; 12: 173-8
52. Bruce WR, Wolever TMS, Giacca A. Mechanisms linking diet and colorectal cancer: The possible role of insulin resistance. Nutr Cancer 2000; 37: 19-26
53. Newmark HL, Wargovich MJ, Bruce WR. Colon cancer and dietary fat, phosphate and calcium: A hypothesis. J Natl Cancer Inst 1984; 72: 1323-5
54. Sorenson AW, Slattery ML, Ford MH. Calcium and colon cancer: A review. Nutr Cancer 1988; 11: 135-45
55. Baron JA, Beach M, Mandel JS et al. Calcium supplements and colorectal adenomas. Polyp Prevention Study Group. Ann NY Acad Sci 1999; 889: 138-45
56. Baron JA, Beach M, Mandel JS et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999; 340: 101-7
57. Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 2000; 356: 1300-6
58. Byers T. Diet, colorectal adenomas, and colorectal cancer. N Engl J Med 2000; 342: 1206-7
59. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002; 94: 437-46
60. Tseng M, Greenberg ER, Sandler RS et al. Serum ferritin concentration and recurrence of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2000; 9: 625-30
61. Sandler RS, Halabi S, Kaplan EB, Baron JA, Paskett E, Petrelli NJ. Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial. Cancer 2001; 91: 1040-5
62. Longnecker MP, Orza MJ, Adams ME et al. A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control 1990; 1: 59-68
63. Zaridze DG. Environmental etiology of large-bowel cancer. J Natl Cancer Inst 1983; 70: 389-400
64. Goldin BR, Gorbach SL. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984; 39: 756-61
65. IARC (International Agency for Research on Cancer) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol 44. Coffee, Tea, Mate, Methylxanthines (Caffeine, Theophylline, Theobromine) and Methylglyoxal. Lyon: IARC, 1988
66. Giovannucci E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol 1998; 147: 1043-52
67. IARC (International Agency for Research on Cancer) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol 38. Tobacco Smoking. Lyon: IARC, 1986
68. Giovannucci E, Rimm EB, Strampfer MJ et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. Men. J Natl Cancer Inst 1994a; 86: 183-91
69. Giovannucci E, Colditz GA, Strampfer MJ et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 1994; 86: 192-9
70. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev 2001; 10: 725-31
71. MacLennan SC, MacLennan AH, Ryan P. Colorectal cancer and oestrogen replacement therapy: A meta-analysis of epidemiological studies. Med J Aust 1995; 162: 491-3
72. Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history and colon cancer. Cancer Causes Control 1994; 5: 359-66
73. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87: 517-23
74. Slattery ML, Anderson K, Samowitz W et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control 1999; 10: 467-73
75. Prihartono N, Palmer JR, Louik C, Shapiro S, Rosenberg L. A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer. Cancer Epidemiol Biomark Prev 2000; 9: 443-7
76. Slattery ML, Potter JD, Curtin K et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon-cancer. Cancer Res 2001; 61: 126-30
77. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomark Prev 1998; 7: 653-9
78. Writing Group for Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Trial. JAMA 2002; 288: 321-33
79. Beral V, Banks E, Reeves G, Appleby P. Use of HRT and the subsequent risk of cancer. J Epidemiol Biol 1999; 4: 191-215
80. Langman MJS, Boyle P. Chemoprevention of colorectal cancer. Gut 1998; 43: 578-585
81. Labayle D, Fischer D, Vielh P et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 307-11
82. Skinner SA, Penny AG, O'Brien PE. Sulindac inhibits the rate of growth and appearance of colon tumours in rats. Arch Surg 1991; 126: 1094-6
83. Pelag I, Maibach HT, Brown SH, Wilcox CM. Aspirin and non-steroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994; 154: 394-9
84. Rosenberg L, Palmer JR, Zauber AG et al. A hypothesis: Non-steroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 1991; 83: 355-8
85. Kune GA, Kune S, Watson JF. Colorectal cancer risk, chronic illnesses, operations and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988; 48: 4399-404
86. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121: 241-6
87. Logan RF, Little J, Hawtin PG, Hardcastle JD. Effect of aspirin and non-steroidal antiinflammatory drugs on colorectal adenomas: Case control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993; 307: 285-9
88. Gann PH, Manson J, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumours in a randomised trial. J Natl Cancer Inst 1993; 85: 1220-4
89. Farmer KC, Goulston K, Macrae E Aspirin and non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Med J Aust 1993; 159: 649-50
90. Langman MJS, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8
91. Sporn M. Chemoprevention of cancer. Lancet 1993; 342: 1211-3
92. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 major cancers in 1990. Int J Cancer 1999; 83: 18-29
93. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71
94. Kewenter J, Brevinge H, Engaras B, Haglind E, Abren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994; 29: 468-73
95. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7
96. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71
97. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998; 317: 559-65
98. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7
99. Boyle P. Faecal occult blood testing (FOBT) as screening for colorectal cancer: The current controversy. Ann Oncol 2002; 13: 6-8
100. Gilbertson VA, Nelms JM. The prevention of invasive cancer of the rectum. Cancer 1978; 41: 1137-9
101. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer: A case-control study. Ann Intern Med 1993; 118: 1294-7
102. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5
103. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658-62
104. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk. Cancer Epidemiol Biomark Prev 1994; 3: 687-95
105. Boyle P. Progress in preventing death from colorectal cancer [Editorial]. Br J Cancer 1995; 72: 528-30